Avadel Pharmaceuticals (AVDL)
(Delayed Data from NSDQ)
$16.20 USD
-0.03 (-0.18%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $16.20 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth F Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AVDL 16.20 -0.03(-0.18%)
Will AVDL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AVDL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVDL
Is Actinium Pharmaceuticals (ATNM) Stock Outpacing Its Medical Peers This Year?
HUM Expands Musculoskeletal Care Access With New Value-Based Tie-Ups
AVDL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Does Avadel (AVDL) Have the Potential to Rally 27.95% as Wall Street Analysts Expect?
Acadia & ECU Health Expand Behavioral Care Access in North Carolina
Corcept Shares Rise 39.6% in YTD: How Should You Play the Stock?
Other News for AVDL
Doji - Bearish? appears for AVDL after 0.18% move
Stochastic Reached Overbought appears for AVDL after 3.64% move
Craig-Hallum Sticks to Their Buy Rating for Avadel Pharmaceuticals (AVDL)
Is AVDL preparing for a move? Bollinger Band Squeeze shows up after gaining 1.62%
Wells Fargo Reaffirms Their Hold Rating on Avadel Pharmaceuticals (AVDL)